Researchers conducted a phase 2B clinical trial that included adult patients with two or more C. diff recurrences. The patients were randomized to receive: • Group C: 67 percent. Thus, one dose of ...

A novel vaccination approach developed by Vanderbilt Health researchers cleared the harmful gut bacterium Clostridioides difficile (C. diff) in an animal model of infection. An experimental vaccine ...

Recurrent C. diff infection is when you contract a C. diff infection 2 to 8 weeks after completing treatment for a previous one. C. diff relapse is a recurrence of the same strain, while reinfection ...